Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 22;20(1):161.
doi: 10.1186/s12874-020-01047-2.

Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19

Mahir Fidahic  1 , Danijela Nujic  2   3 , Renata Runjic  4 , Marta Civljak  5 , Filipa Markotic  6 , Zvjezdana Lovric Makaric  7 , Livia Puljak  8
Affiliations

Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19

Mahir Fidahic et al. BMC Med Res Methodol. .

Abstract

Background: The research community reacted rapidly to the emergence of COVID-19. We aimed to assess characteristics of journal articles, preprint articles, and registered trial protocols about COVID-19 and its causal agent SARS-CoV-2.

Methods: We analyzed characteristics of journal articles with original data indexed by March 19, 2020, in World Health Organization (WHO) COVID-19 collection, articles published on preprint servers medRxiv and bioRxiv by April 3, 2010. Additionally, we assessed characteristics of clinical trials indexed in the WHO International Clinical Trials Registry Platform (WHO ICTRP) by April 7, 2020.

Results: Among the first 2118 articles on COVID-19 published in scholarly journals, 533 (25%) contained original data. The majority was published by authors from China (75%) and funded by Chinese sponsors (75%); a quarter was published in the Chinese language. Among 312 articles that self-reported study design, the most frequent were retrospective studies (N = 88; 28%) and case reports (N = 86; 28%), analyzing patients' characteristics (38%). Median Journal Impact Factor of journals where articles were published was 5.099. Among 1088 analyzed preprint articles, the majority came from authors affiliated in China (51%) and were funded by sources in China (46%). Less than half reported study design; the majority were modeling studies (62%), and analyzed transmission/risk/prevalence (43%). Of the 927 analyzed registered trials, the majority were interventional (58%). Half were already recruiting participants. The location for the conduct of the trial in the majority was China (N = 522; 63%). The median number of planned participants was 140 (range: 1 to 15,000,000). Registered intervention trials used highly heterogeneous primary outcomes and tested highly heterogeneous interventions; the most frequently studied interventions were hydroxychloroquine (N = 39; 7.2%) and chloroquine (N = 16; 3%).

Conclusions: Early articles on COVID-19 were predominantly retrospective case reports and modeling studies. The diversity of outcomes used in intervention trial protocols indicates the urgent need for defining a core outcome set for COVID-19 research. Chinese scholars had a head start in reporting about the new disease, but publishing articles in Chinese may limit their global reach. Mapping publications with original data can help finding gaps that will help us respond better to the new public health emergency.

Keywords: COVID-19; Clinical trial; Coronavirus; Original research; Preprint; Protocol; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Livia Puljak is Section Editor of the BMC Medical Research Methodology. Other authors declare no competing interests.

References

    1. World Health Organization. Novel coronavirus - China. URL: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 18 June 2020.
    1. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica...(covid-2019)-and-the-virus-that-causes-it. Accessed 18 June 2020.
    1. Worldometer. COVID-19 coronavirus outbreak. URL: https://www.worldometers.info/coronavirus/. Accessed 18 June 2020.
    1. Civljak R, Markotic A, Kuzman I. The third coronavirus epidemic in the third millennium: what's next? Croat Med J. 2020;61(1):1–4. doi: 10.3325/cmj.2020.61.1. - DOI - PMC - PubMed
    1. World Health Organization. Database of publications on coronavirus disease (COVID-19). URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-r.... Accessed 18 June 2020.

MeSH terms

LinkOut - more resources